How does proton pump inhibitor [esomeprazole] therapy impact quality of life in patients newly diagnosed with erosive reflux esophagitis?

Trial Profile

How does proton pump inhibitor [esomeprazole] therapy impact quality of life in patients newly diagnosed with erosive reflux esophagitis?

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2010

At a glance

  • Drugs Esomeprazole (Primary)
  • Indications Erosive oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 May 2010 Actual patient number (65) added as reported by ClinicalTrials.gov.
    • 26 Aug 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 26 Aug 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top